These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2137141)

  • 21. Androgen excess: Investigations and management.
    Lizneva D; Gavrilova-Jordan L; Walker W; Azziz R
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():98-118. PubMed ID: 27387253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
    Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
    Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of clinical response in hirsute women treated with spironolactone.
    Crosby PD; Rittmaster RS
    Fertil Steril; 1991 Jun; 55(6):1076-81. PubMed ID: 1828043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of spironolactone in dermatology.
    Rathnayake D; Sinclair R
    Skinmed; 2010; 8(6):328-32; quiz 333. PubMed ID: 21413648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance of spironolactone.
    Hughes BR; Cunliffe WJ
    Br J Dermatol; 1988 May; 118(5):687-91. PubMed ID: 2969259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of androgenic disorders in women: acne, hirsutism, and alopecia.
    Redmond GP; Bergfeld WF
    Cleve Clin J Med; 1990; 57(5):428-32. PubMed ID: 2142638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen excess in women with acne.
    Scholl GM; Wu CH; Leyden J
    Obstet Gynecol; 1984 Nov; 64(5):683-8. PubMed ID: 6238252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen excess in cystic acne.
    Marynick SP; Chakmakjian ZH; McCaffree DL; Herndon JH
    N Engl J Med; 1983 Apr; 308(17):981-6. PubMed ID: 6220224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects and side-effects of spironolactone therapy in women with acne.
    Yemisci A; Gorgulu A; Piskin S
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):163-6. PubMed ID: 15752283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hormonotherapy in acute, idiopathic hirsutism, and seborrheic alopecia (author's transl)].
    Belaube P; Devaux J; Gamby T; Garcin G; Privat Y
    Sem Hop; 1982 Jul; 58(26-27):1650-3. PubMed ID: 6287643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Baldness, and Hirsutism.
    Vargas-Mora P; Morgado-Carrasco D
    Actas Dermosifiliogr (Engl Ed); 2020 Oct; 111(8):639-649. PubMed ID: 32571540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E; Stanczyk FZ; Matteri RK; Lobo RA
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovulation induction in clomiphene-resistant anovulatory women with normal dehydroepiandrosterone sulfate levels: beneficial effects of the addition of dexamethasone during the follicular phase.
    Trott EA; Plouffe L; Hansen K; Hines R; Brann DW; Mahesh VB
    Fertil Steril; 1996 Sep; 66(3):484-6. PubMed ID: 8751754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
    Coenen CM; Thomas CM; Borm GF; Rolland R
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():92-7. PubMed ID: 8574256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women.
    Glickman SP; Rosenfield RL; Bergenstal RM; Helke J
    J Clin Endocrinol Metab; 1982 Aug; 55(2):251-7. PubMed ID: 6282921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prolonged remission of female hyperandrogenism after discontinuing glucocorticoid therapy].
    Devoto E; Aravena L; Gaete X
    Rev Med Chil; 1995 Feb; 123(2):207-14. PubMed ID: 7569461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acne, hirsutism and androgenic alopecia].
    Dobrić I; Basta-Juzbasić A; Matesa-Gregurić S
    Lijec Vjesn; 1996 Mar; 118 Suppl 1():48-51. PubMed ID: 8759410
    [No Abstract]   [Full Text] [Related]  

  • 39. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
    Rubina VV; Korchevaia TA; Kravchenko LIa
    Vestn Dermatol Venerol; 1986; (7):21-5. PubMed ID: 2945335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.